Home/Filings/4/0001185185-26-000218
4//SEC Filing

PRINS RICHARD K 4

Accession 0001185185-26-000218

CIK 0001326205other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:01 PM ET

Size

7.2 KB

Accession

0001185185-26-000218

Insider Transaction Report

Form 4
Period: 2026-01-19
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-19+100,0001,371,251 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F1]
    2026-01-19100,00050,000 total
    Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]On March 13, 2024, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.
  • [F2]Each restricted stock unit represents a right to receive one share of IGC common stock.
Signature
/s/ Richard Prins|2026-01-20

Documents

1 file

Issuer

IGC Pharma, Inc.

CIK 0001326205

Entity typeother

Related Parties

1
  • filerCIK 0001047579

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:01 PM ET
Size
7.2 KB